Pharmaceutical group ยท Germany
B. Braun
A group of 28 companies with 900 medicines in 12 countries.
Loading your pageโฆ
Pharmaceutical group ยท Germany
A group of 28 companies with 900 medicines in 12 countries.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
28 companies in 15 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 900
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 200 mg / 100 ml ยท Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1998 |
| 0.45% SODIUM CHLORIDE INJECTION USP4.5 mg / ml ยท Solution | Sodium chloride | Canada | Marketed | 1993 |
| 0.9% SODIUM CHLORIDE INJECTION USP0.9 % ยท Solution | Sodium chloride | Canada | Marketed | 1992 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP0.9 % ยท Solution | Sodium chloride | Canada | Not marketed | 1992 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP0.9 % ยท Solution | Sodium chloride | Canada | Authorised | |
| 10% DEXTROSE INJECTION USP100 mg / ml ยท Solution | Dextrose | Canada | Marketed | 1993 |
| 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 300 mg / 100 ml ยท Solution | Dextrose, Sodium chloride | Canada | Not marketed | 1992 |
| 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 200 mg / 100 ml ยท Solution | Dextrose, Sodium chloride | Canada | Not marketed | 1996 |
| 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 450 mg / 100 ml ยท Solution | Dextrose, Sodium chloride | Canada | Marketed | 1992 |
| 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP50 mg / ml + 9 mg / ml ยท Solution | Dextrose, Sodium chloride | Canada | Marketed | 1992 |
| 5% DEXTROSE INJECTION USP50 mg / ml ยท Solution | Dextrose | Canada | Marketed | 1993 |
| 5% SODIUM CHLORIDE INJECTION USP5 g / 100 ml ยท Solution | Sodium chloride | Canada | Marketed | 1993 |
| 70% DEXTROSE INJECTION USP70 g / 100 ml ยท Solution | Dextrose | Canada | Authorised | |
| ACETAMINOPHEN INJECTION500 mg / 50 ml ยท Solution | Paracetamol | Canada | Marketed | 2023 |
| ACETAMINOPHEN INJECTION100 mg / 10 ml ยท Solution | Paracetamol | Canada | Marketed | 2023 |
| ACETAMINOPHEN INJECTION1000 mg / 100 ml ยท Solution | Paracetamol | Canada | Marketed | 2024 |
| ACETATED RINGER'S IN PLASTIC CONTAINER20mg/100ml; 30mg/100ml; 380mg/100ml; 600mg/100ml ยท Injectable | Calcium chloride, Potassium chloride, Sodium acetate, Sodium chloride | United States | Not marketed | 1982 |
| ACETATO DE POTASIO B.BRAUN 1 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION980 mg ยท Concentrado para soluciรณn para perfusiรณn | Potassium | Spain | Marketed | 2001 |
| ACETIC ACID 0.25% IN PLASTIC CONTAINER250mg/100ml ยท Solution | Acetic acid, Glacial | United States | Marketed | 1976 |
| ACQUA PER PREPARAZIONI INIETTABILI B. BRAUNSolvente per uso parenterale | Acqua preparazioni iniettabili | Italy | Authorised | |
| ADRENALINA B. BRAUN 1 mg/ml SOLUCION INYECTABLE1,8 mg ยท Soluciรณn inyectable | Epinefrina bitartrato | Spain | Marketed | 2007 |
| รGUA PARA INJEรรO B. BRAUN | รgua para injetรกveis, รgua para injetรกveis qsp, รgua para injeรงรฃo | Brazil | Authorised | 1999 |
| AGUA PARA PREPARACIONES INYECTABLES B.BRAUN DISOLVENTE PARA USO PARENTERAL1 ml ยท Disolvente para uso parenteral | Agua para preparaciones inyectables | Spain | Marketed | 1990 |
| ALCOHOL 5% AND DEXTROSE 5%5ml/100ml; 5gm/100ml ยท Injectable | Alcohol, Dextrose | United States | Not marketed | 1946 |
| AMENIFLAC | Paracetamol | Brazil | Authorised | 2020 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 195 | 195 | 0 | CompaniesAll medicines |
| Spain | 138 | 116 | 22 | CompaniesAll medicines |
| Saudi Arabia | 77 | 77 | 0 | CompaniesAll medicines |
| Canada | 73 | 37 | 36 | CompaniesAll medicines |
| Brazil | 67 | 27 | 40 | CompaniesAll medicines |
| Taiwan | 67 | 6 | 61 |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
| CompaniesAll medicines |
| Netherlands | 62 | 62 | 0 | CompaniesAll medicines |
|---|
| Singapore | 61 | 61 | 0 | CompaniesAll medicines |
|---|
| Romania | 52 | 0 | 52 | CompaniesAll medicines |
|---|
| Serbia | 46 | 46 | 0 | CompaniesAll medicines |
|---|
| Italy | 40 | 40 | 0 | CompaniesAll medicines |
|---|
| Croatia | 22 | 22 | 0 | CompaniesAll medicines |
|---|
Also in the registers of France, United Kingdom
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA factual register
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
State Enterprise Centre of Registers / Valstybฤs ฤฏmonฤ Registrลณ centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence: Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Naศional al Registrului Comerศului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Register prรกvnickรฝch osรดb, podnikateฤพov a orgรกnov verejnej moci; public API licence names ล tatistickรฝ รบrad Slovenskej republiky; administration transferred to Ministerstvo vnรบtra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence: Creative Commons Attribution
Slovak Ministry of Finance, Register รบฤtovnรฝch zรกvierok (RรZ) Open API; exact IฤO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence: CC0
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Licence: Taiwan Government Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.